Viatris (VTRS) Income from Continuing Operations (2019 - 2026)

Viatris (VTRS) recorded quarterly Income from Continuing Operations of 176400000.0 in Q1 2026, up 151.87% quarter-over-quarter from 340100000.0 in Q4 2025, and up 105.8% on a YoY basis from 85714778.61 in Q1 2025.

Viatris (VTRS) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Viatris' Income from Continuing Operations history runs 8 years deep, the most recent figure standing at 176400000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 105.8% year-over-year to 176400000.0; the TTM figure through Mar 2026 stood at 296500000.0 (up 92.18% YoY), while the FY2025 annual figure was 3514900000.0, down 454.23% from the prior year.
  • Income from Continuing Operations was 176400000.0 for Q1 2026 at Viatris, up from 340100000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1011200000.0 in Q4 2022 to a low of 3042000000.0 in Q1 2025.
  • Historically, Income from Continuing Operations has averaged 103747058.82 across 5 years, with a median of 113900000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations jumped 483.32% in 2022, then slumped 2770.76% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 1011200000.0 in 2022, then plunged by 175.71% to 765600000.0 in 2023, then surged by 32.54% to 516500000.0 in 2024, then jumped by 34.15% to 340100000.0 in 2025, then jumped by 151.87% to 176400000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 176400000.0 (Q1 2026), 340100000.0 (Q4 2025), and 128200000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Viatris - - 1.16 Bn 176.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 176.40 Mn
Dec 31, 2025 -340.10 Mn
Sep 30, 2025 -128.20 Mn
Jun 30, 2025 -4.60 Mn
Mar 31, 2025 -3.04 Bn
Dec 31, 2024 -516.50 Mn
Sep 30, 2024 94.80 Mn
Jun 30, 2024 -326.40 Mn
Mar 31, 2024 113.90 Mn
Dec 31, 2023 -765.60 Mn
Sep 30, 2023 331.60 Mn
Jun 30, 2023 264.00 Mn
Mar 31, 2023 300.40 Mn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 354.30 Mn
Jun 30, 2022 313.90 Mn
Mar 31, 2022 399.20 Mn
Dec 31, 2021 -263.80 Mn
Sep 30, 2021 311.50 Mn
Jun 30, 2021 -279.20 Mn